Sexual behaviour of women living with HIV/AIDS naïve for antiretroviral therapy: The ICONA-BEHEPI Study

AIDS Care ◽  
2000 ◽  
Vol 12 (6) ◽  
pp. 789-795 ◽  
Author(s):  
M. S. Aloisi ◽  
D. Serraino ◽  
E. Girardi ◽  
F. N. Lauria ◽  
A. D'Arminio Monforte ◽  
...  
Keyword(s):  
Antiretroviral Therapy ◽  
Sexual Behaviour ◽  
Women Living With Hiv ◽  
Living With Hiv ◽  
Hiv Aids

scholarly journals MENSTRUAL PERIOD ANALISIS OF WOMEN PLWHA WITH ANTI RETROVIRAL THERAPY (ART) IN NGO LANCANG KUNING PEKANBARU CITY

1930 ◽  
Vol 8 (01) ◽  
pp. 147-154
Author(s):  
Dona Martilova ◽  
Husna Farianti Amran
Keyword(s):  
Antiretroviral Therapy ◽  
Nutritional Status ◽  
Good Condition ◽  
Sampling Technique ◽  
Antiretroviral Drugs ◽  
P Value ◽  
Cross Sectional ◽  
Women Living With Hiv ◽  
Living With Hiv ◽  
Hiv Aids

Acquired Immunodeficiency Syndrome (AIDS) is caused by Human Immunodeficiency Virus (HIV), including infectious diseases that cause weakness of the immune system. Riau province on the 11st grade of most cases of AIDS that is 1104 cases and 53% occur in women. Treatment that can be done is to use antiretroviral therapy (ART). ARV drugs do not kill the virus but can slow the growth of the virus. The use of antiretroviral drugs can cause side effects in some women the use of antiretroviral drugs causes menstrual disorders such as prolonged bleeding, menstrual bleeding time, faster menstrual periods, longer menstrual intervals, and, periods sometimes do not occur.The research type is quantitative with cross sectional approach. The study was conducted from May to December 2017. The study population was all women living with HIV / AIDS under the guidance of NGO Lancang Kuning Pekanbaru which amounted to 96 people with a sample of 53 people taken with Simple Random Sampling technique (simple random), Instrument data collection is a questionnaire in the form of a list question and checklist list. Data were analyzed by Univariate to know the frequency distribution of respondent, and Bivariate (chi-square) to know the relation between variables. The results showed that menstrual cycle disorders in HIV-positive women were associated with age (P value 0.001), duration of use of antiretroviral therapy (P value 0.004), nutritional status of women living with HIV (P value 0,003) and environmental factor (P value 0,000). It is recommended that women living with HIV / AIDS can take Anti retroviral medication regularly and maintain their nutritional status in good condition and it is expected that the environment can provide support to PLHIV women.

scholarly journals Adherence to antiretroviral therapy among women living with HIV/AIDS in the interior of the Brazilian state of Pará: cross-sectional study

2021 ◽  
Vol 139 (2) ◽  
pp. 99-106
Author(s):  
Paula Gabrielle Gomes Candido ◽  
Bruna Melo Amador ◽  
Fabricio Ferreira Silva ◽  
Floriacy Stabnow Santos ◽  
Luiz Marcelo de Lima Pinheiro ◽  
...  
Keyword(s):  
Antiretroviral Therapy ◽  
Cross Sectional Study ◽  
Sectional Study ◽  
Cross Sectional ◽  
Women Living With Hiv ◽  
Brazilian State ◽  
Living With Hiv ◽  
Hiv Aids

Neuropsychological functioning in a cohort of HIV infected women: Importance of antiretroviral therapy

2002 ◽  
Vol 8 (6) ◽  
pp. 781-793 ◽  
Author(s):  
JEAN L. RICHARDSON ◽  
EILEEN M. MARTIN ◽  
NORA JIMENEZ ◽  
KATHLEEN DANLEY ◽  
MARDGE COHEN ◽  
...  
Keyword(s):  
Antiretroviral Therapy ◽  
Test Performance ◽  
Neuropsychological Functioning ◽  
Women Living With Hiv ◽  
Hiv Positive Women ◽  
Increased Risk ◽  
Multi Center Study ◽  
Living With Hiv ◽  
Hiv Seropositive ◽  
Hiv Aids

We evaluated neurocognitive function in 149 HIV-seropositive and 82 seronegative women enrolled in the Women's Interagency HIV Study (WIHS), a large multi-center study of disease progression in women living with HIV/AIDS. We evaluated the prevalence of abnormal neuropsychological (NP) test findings in HIV-seropositive and seronegative women and factors associated with increased risk of abnormal NP test performance. Risk of NP impairment was no higher for HIV positive women receiving antiretroviral therapy at testing than for HIV-negative women (OR = 1.00). However, the risk of abnormal NP performance increased significantly for seropositive women not receiving antiretroviral therapy (OR = 2.43). Further, treatment status was a significant predictor of NP impairment in a multivariate analysis that included viral load (OR = 1.48) and CD4 count (OR = 1.08) which were not significant. The multivariate analyses controlled for substance use, age, education, head injury, ethnicity, estimated IQ, and psychological distress. This study emphasizes the critical association of antiretroviral therapy with the risk of neurocognitive impairment in women living with HIV/AIDS. (JINS, 2002, 8, 781–793.)

scholarly journals Childbearing Decision Making: A Qualitative Study of Women Living with HIV/AIDS in Southwest Nigeria

2012 ◽  
Vol 2012 ◽  
pp. 1-8 ◽  
Author(s):  
Y. A. Sofolahan ◽  
C. O. Airhihenbuwa
Keyword(s):  
Decision Making ◽  
Antiretroviral Therapy ◽  
Qualitative Study ◽  
Partner Support ◽  
Women Living With Hiv ◽  
Sexual Reproductive Health ◽  
Southwest Nigeria ◽  
Living With Hiv ◽  
Depth Interviews ◽  
Hiv Aids

Using the PEN-3 model, the purpose of this qualitative study was to understand the factors responsible for the childbearing decisions of women living with HIV/AIDS (WLHA) in Lagos, Nigeria. Sixty WLHA who sought care at a teaching hospital in Lagos were recruited to participate in in-depth interviews. The average age of the participants was 30 years, and 48 participants were receiving antiretroviral therapy. Healthcare and spiritual practices, healthcare provider-patient communication about childbearing, and husband/partner support emerged as factors that contribute to the childbearing decisions of WLHA. The findings reveal the importance of discussing sexual reproductive health and childbearing issues with WLHA in the healthcare context prior to pregnancy.

Social Vulnerability among Foreign-Born Pregnant Women and Maternal Virologic Control of HIV

2020 ◽  
Author(s):  
Ashish Premkumar ◽  
Lynn M. Yee ◽  
Lia Benes ◽  
Emily S. Miller
Keyword(s):  
Antiretroviral Therapy ◽  
Pregnant Women ◽  
Median Time ◽  
Social Vulnerability ◽  
Viral Suppression ◽  
Foreign Born ◽  
Women Living With Hiv ◽  
Virologic Control ◽  
Clinical Records ◽  
Living With Hiv

Objective The aim of this study was to assess whether social vulnerability among foreign-born pregnant women living with HIV is associated with maternal viremia during pregnancy. Study Design This retrospective cohort study included all foreign-born pregnant women living with HIV who received prenatal care in a multidisciplinary prenatal clinic between 2009 and 2018. A licensed clinical social worker evaluated all women and kept detailed clinical records on immigration status and social support. Social vulnerability was defined as both living in the United States for less than 5 years and reporting no family or friends for support. The primary outcome was evidence of viral non-suppression after achievement of initial suppression. Secondary outcomes were the proportion of women who required > 12 weeks after starting antiretroviral therapy to achieve viral suppression, median time to first viral suppression (in weeks) after initiation of antiretroviral therapy, and the proportion who missed ≥ 5 doses of antiretroviral therapy. Bivariable analyses were performed. Results A total of 111 foreign-born women were eligible for analysis, of whom 25 (23%) were classified as socially vulnerable. Social and clinical characteristics of women diverged by social vulnerability categorization but no differences reached statistical significance. On bivariable analysis, socially-vulnerable women were at increased risk for needing > 12 weeks to achieve viral suppression (relative risk: 1.78, 95% confidence interval: 1.18–2.67), though there was no association with missing ≥ 5 doses of antiretroviral therapy or median time to viral suppression after initiation of antiretroviral therapy. Conclusion Among foreign-born, pregnant women living with HIV, markers of virologic control during pregnancy were noted to be worse among socially-vulnerable women. Insofar as maternal viremia is the predominant driver of perinatal transmission, closer clinical surveillance and support may be indicated in this population. Key Points

Sign in / Sign up

Export Citation Format

Share Document